Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Calvert International Equity A CWVGX
- NAV / 1-Day Return 22.57 / −0.27 %
- Total Assets 1.0 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.140%
- Distribution Fee Level Below Average
- Share Class Type Front Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Limited
- TTM Yield 0.80%
- Turnover 35%
USD | NAV as of Mar 18, 2024 | 1-Day Return as of Mar 18, 2024, 10:14 PM GMT+0
Morningstar’s Analysis CWVGX
Will CWVGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 39.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Nestle SA | 5.77 | 57.1 Mil | Consumer Defensive |
AstraZeneca PLC | 4.47 | 44.3 Mil | Healthcare |
Reckitt Benckiser Group PLC | 4.17 | 41.3 Mil | Consumer Defensive |
ASML Holding NV | 4.01 | 39.7 Mil | Technology |
Novo Nordisk A/S Class B | 3.94 | 39.1 Mil | Healthcare |
Compass Group PLC | 3.62 | 35.8 Mil | Consumer Cyclical |
Sanofi SA | 3.57 | 35.4 Mil | Healthcare |
Iberdrola SA | 3.53 | 35.0 Mil | Utilities |
CSL Ltd | 3.09 | 30.6 Mil | Healthcare |
Siemens AG | 3.08 | 30.5 Mil | Industrials |